<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR8">
 <label>8.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tram</surname>
    <given-names>KH</given-names>
   </name>
   <name>
    <surname>Mwangwa</surname>
    <given-names>F</given-names>
   </name>
   <name>
    <surname>Atukunda</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Owaraganise</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Ayieko</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Plenty</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Kwariisima</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>TD</given-names>
   </name>
   <name>
    <surname>Petersen</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Charlebois</surname>
    <given-names>ED</given-names>
   </name>
   <name>
    <surname>Kamya</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Chamie</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Havlir</surname>
    <given-names>DV</given-names>
   </name>
   <name>
    <surname>Marquez</surname>
    <given-names>C</given-names>
   </name>
  </person-group>
  <article-title>search collaboration isoniazid preventive therapy completion in the era of differentiated HIV care</article-title>
  <source>PMJ Acquir Immune Defic Syndr.</source>
  <year>2017</year>
  <volume>76</volume>
  <fpage>5</fpage>
 </element-citation>
</ref>
